Lucintel's latest study found that, the future of the global bio-process technology market looks promising with opportunities in the biopharmaceutical, contract manufacturing organization, and academic research institute markets. The global bio-process technology market is expected to reach an estimated $71.7 billion by 2030 with a CAGR of 12.3% from 2024 to 2030. The major drivers for this market are growing demand for next-generation bio-based products and rising prevalence of chronic diseases.
In this market, biologics safety testing, cell culture, cell expansion,
cell line development, flow cytometry, tangential flow filtration, and flow
cytometry are the major segments of bio-process technology market by product
type.
Lucintel forecasts that biologics safety testing is expected to witness
the highest growth over the forecast period.
Browse in depth TOC of the Bio-Process Technology Market:
100 - Figures
150-Pages
Bio-Process Technology Market is marked by presence of several big and
small players. Hoffmann-La Roche, Sartorius, Thermo Fisher Scientific, Agilent,
and Elitech are the major suppliers in the bio-process technology market.
This unique research report will enable you
to make confident business decisions in this globally competitive marketplace. For
a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on
this link helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global
management consulting and market research firm, creates winning strategies for
growth. It offers market assessments, competitive analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Explore Our Latest
Publications
RTLS for Healthcare Market
No comments:
Post a Comment